Michael Cooke
26Patents
4h-index
47Co-inventors
63Inventor score
Filing activity: Jul 21, 1988 → Mar 7, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6148480A | Hinge construction with a snap-open, snap-shut feel, for a folding mobile phone handset | Fixed Constructions | 41 | Expired |
| US6451558B1 | Genes in the control of hematopoiesis | Chemistry; Metallurgy | 26 | Expired |
| US6033630A | Method and sensor for detecting volatile enantiomeric substances in gases | Physics | 5 | Expired |
| US9580426B2 | Compounds that expand hematopoietic stem cells | Chemistry; Metallurgy | 4 | Active |
| US5584999A | Edge filter with v-shaped channels | Performing Operations; Transporting | 4 | Expired |
| US8927281B2 | Method for expanding hematopoietic stem cells | Chemistry; Metallurgy | 4 | Active |
| US4924190A | Amplifiers | Electricity | 2 | Expired |
| US10899843B2 | Compositions and methods for the depletion of CD117+ cells | Emerging Cross-Sectional Technologies | 1 | Active |
| US10058573B1 | Dosing regimens for the mobilization of hematopoietic stem cells | Emerging Cross-Sectional Technologies | 1 | Active |
| US9834755B2 | Compositions and methods for enhanced generation of hematopoietic stem/progenitor cells | Chemistry; Metallurgy | 1 | Active |
| US10434185B2 | Compositions and methods for the depletion of CD137+ cells | Chemistry; Metallurgy | 0 | Active |
| US7595148B2 | Methods and compositions for modulating T lymphocytes | Physics | 0 | Expired |
| US11694709B2 | Audio signal | Electricity | 0 | Active |
| US12291576B2 | Anti-CD45 antibodies and conjugates thereof | Chemistry; Metallurgy | 0 | Active |
| US11357864B2 | Antibody drug conjugates for ablating hematopoietic stem cells | Chemistry; Metallurgy | 0 | Active |
| US11752162B2 | Compounds and compositions for treating solid tumors by intratumoral administration | Human Necessities | 0 | Active |
| US12251448B2 | Compositions and methods for the depletion of CD5+ cells | Chemistry; Metallurgy | 0 | Active |
| US11958908B2 | Compositions and methods for the depletion of CD117+ cells | Emerging Cross-Sectional Technologies | 0 | Active |
| US11260079B2 | Dosing regimens for the mobilization of hematopoietic stem and progenitor cells | Human Necessities | 0 | Active |
| US12006370B2 | Use of anti-CD5 antibody drug conjugate (ADC) in allogeneic cell therapy | Chemistry; Metallurgy | 0 | Active |
| US9837108B2 | Magnetic sensor and a method and device for mapping the magnetic field or magnetic field sensitivity of a recording head | Emerging Cross-Sectional Technologies | 0 | Active |
| US10576161B2 | Compositions and methods for the depletion of CD137+ cells | Chemistry; Metallurgy | 0 | Active |
| US12209135B2 | Anti-CD45 antibodies and conjugates thereof | Chemistry; Metallurgy | 0 | Active |
| US12403185B2 | Use of anti-CD137 antibody drug conjugate (ADC) in allogeneic cell therapy | Chemistry; Metallurgy | 0 | Active |
| US12171839B2 | Antibody drug conjugates for ablating hematopoietic stem cells | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.